Greenway Announces Audited Year End Financial Results
29-07-2026 23:15 via prnewswire.com

Greenway Announces Audited Year End Financial Results

Achieves Record Average Selling Price, Improved Underlying Margins and Continued Expansion of International Sales KINGSVILLE, ON, July 29, 2026 /PRNewswire/ -- Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) ("Greenway" or the "Company"), a cultivator of high-quality...
Read more »

PR Public relations news



Rep Data Announces Executive Leadership Promotions Supporting Next Phase Of Growth
Rep Data Announces Executive Leadership Promotions Supporting Next Phase Of Growth
Nomad Foods to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
Nomad Foods to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
MPC Sales Improved at Mid-Year despite broader new home market decline in June of 5.6% YoY According to RCLCO Real Estate Consulting's 2026 Mid-Year Master-Planned Communities Report
MPC Sales Improved at Mid-Year despite broader new home market decline in June of 5.6% YoY According to RCLCO Real Estate Consulting's 2026 Mid-Year Master-Planned Communities Report
MCBANK Selects Jack Henry to Power Relationship-Driven Banking
MCBANK Selects Jack Henry to Power Relationship-Driven Banking
MAINGEAR Unveils Next-Gen 'Zero' Gaming Desktop PCs: Engineered for Unrelenting Performance, Designed for Unobstructed Visibility
Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026
Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026
LogicGate Honors GRC Trailblazers at Agility 2026 Conferences
LogicGate Honors GRC Trailblazers at Agility 2026 Conferences
LA OPINIÓN FAVORABLE DEL CHMP RESPALDA UN USO MÁS AMPLIO DE REPATHA® DE AMGEN
LA OPINIÓN FAVORABLE DEL CHMP RESPALDA UN USO MÁS AMPLIO DE REPATHA® DE AMGEN
Johnson & Johnson's RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer
Johnson & Johnson's RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer
IAB Tech Lab Releases AAMP 2.3, Bringing Enterprise-Grade Infrastructure and Privacy Diligence to Agentic Advertising
IAB Tech Lab Releases AAMP 2.3, Bringing Enterprise-Grade Infrastructure and Privacy Diligence to Agentic Advertising
CW Bancorp Reports Second Quarter 2026 Financial Results
CW Bancorp Reports Second Quarter 2026 Financial Results
C4® Expands Beyond Energy Drinks with the Launch of Sparkling Protein
C4® Expands Beyond Energy Drinks with the Launch of Sparkling Protein
Beauty Creations Lands at CVS Pharmacy, Marking Its Biggest Retail Milestone Yet
Beauty Creations Lands at CVS Pharmacy, Marking Its Biggest Retail Milestone Yet
Bank of Botetourt announces second quarter financial results and quarterly cash dividend
Desktop versie